MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma

MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients

(2015) Kai Doberstein et al.   NEOPLASIA

RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-Kinase/Myosin phosphatase target pathway

(2012) Wei Ma et al.   HEPATOLOGY

Regulation of ROCK Activity in Cancer

(2012) Marie Morgan-Fisher et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

(2010) T Chiyomaru et al.   BRITISH JOURNAL OF CANCER

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

(2010) A. P. Venook et al.   ONCOLOGIST

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA